Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...

Vertex, Inc. VERX is scheduled to report fourth-quarter 2024 results before market open on Feb. 27. Find the latest EPS ...

Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...

Anthropic AI has released their Claude 3.7 Sonnet, a hybrid reasoning model said to be their most advanced AI model yet.

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...

Agentforce will be able to use Google’s Gemini models, allowing agents to work with images, audio, video, and handle more ...

Accenture is helping organizations supercharge growth and customer experiences with AI from Google Cloud and Salesforce.

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Anthropic today announced the immediate availability of Claude 3.7 Sonnet, its first reasoning AI model, to all customers.

As the country faces significant energy challenges, including rising electricity prices, grid instability, and heavy reliance on fossil fuels, a shift towards renewable energy is gaining momentum.

This high-profile collaboration may spur similar deals across the industry as organizations seek the best mix of software and ...

Artificial intelligence startup Anthropic has released Claude 3.7 Sonnet, the world's first "hybrid reasoning" AI model that ...